<SEC-DOCUMENT>0001628280-26-046936-index.html : 20260702
<SEC-HEADER>0001628280-26-046936.hdr.sgml : 20260702
<ACCEPTANCE-DATETIME>20260702162752
ACCESSION NUMBER:		0001628280-26-046936
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20260701
FILED AS OF DATE:		20260702
DATE AS OF CHANGE:		20260702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Telix Pharmaceuticals Ltd
		CENTRAL INDEX KEY:			0002007191
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42128
		FILM NUMBER:		261151756

	BUSINESS ADDRESS:	
		STREET 1:		55 FLEMINGTON ROAD
		CITY:			NORTH MELBOURNE
		STATE:			C3
		ZIP:			3051
		BUSINESS PHONE:		61 3 9093 3855

	MAIL ADDRESS:	
		STREET 1:		55 FLEMINGTON ROAD
		CITY:			NORTH MELBOURNE
		STATE:			C3
		ZIP:			3051
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>telix-6kforprostactglobalp.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: telix-6kforprostactglobalp.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a20260702fdaalignmentpro.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: a20260702fdaalignmentpro.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>a20260702fdaalignmentpro001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: a20260702fdaalignmentpro001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>a20260702fdaalignmentpro002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: a20260702fdaalignmentpro002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>a20260702fdaalignmentpro003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: a20260702fdaalignmentpro003.jpg

</DOCUMENT>
</SEC-DOCUMENT>